[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

UA107919C2 - Anti-wrinkle means - Google Patents

Anti-wrinkle means

Info

Publication number
UA107919C2
UA107919C2 UAA201107663A UAA201107663A UA107919C2 UA 107919 C2 UA107919 C2 UA 107919C2 UA A201107663 A UAA201107663 A UA A201107663A UA A201107663 A UAA201107663 A UA A201107663A UA 107919 C2 UA107919 C2 UA 107919C2
Authority
UA
Ukraine
Prior art keywords
wrinkles
wrinkle means
wrinkle
stereoisomers
cosmetics
Prior art date
Application number
UAA201107663A
Other languages
English (en)
Ukrainian (uk)
Inventor
Noriko Suenobu
Chihiro Kondo
Takashi Yamasaki
Original Assignee
Pola Chem Ind Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pola Chem Ind Inc filed Critical Pola Chem Ind Inc
Publication of UA107919C2 publication Critical patent/UA107919C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/463—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfuric acid derivatives, e.g. sodium lauryl sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C201/00—Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/17—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing carboxyl groups bound to the carbon skeleton
    • C07C309/18—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing carboxyl groups bound to the carbon skeleton containing amino groups bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/52—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
UAA201107663A 2008-11-19 2009-12-11 Anti-wrinkle means UA107919C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2008294995 2008-11-19
PCT/JP2009/069261 WO2010058730A1 (ja) 2008-11-19 2009-11-12 シワ改善剤

Publications (1)

Publication Number Publication Date
UA107919C2 true UA107919C2 (en) 2015-03-10

Family

ID=42198170

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201107663A UA107919C2 (en) 2008-11-19 2009-12-11 Anti-wrinkle means

Country Status (17)

Country Link
US (1) US8835498B2 (ru)
EP (2) EP3173063B1 (ru)
JP (3) JP5746864B2 (ru)
KR (1) KR101657323B1 (ru)
CN (1) CN102215812B (ru)
AU (1) AU2009318483B2 (ru)
BR (1) BRPI0921303B8 (ru)
CA (1) CA2742909C (ru)
ES (2) ES2650252T3 (ru)
HK (1) HK1160405A1 (ru)
IL (1) IL212909A (ru)
MX (1) MX2011004006A (ru)
MY (1) MY159355A (ru)
RU (1) RU2503443C2 (ru)
TW (1) TWI474837B (ru)
UA (1) UA107919C2 (ru)
WO (1) WO2010058730A1 (ru)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2011206133B2 (en) * 2010-01-12 2014-09-18 Pola Chemical Industries Inc. Prophylactic or ameliorating agent for pigmentation
JP5666158B2 (ja) * 2010-03-31 2015-02-12 ポーラ化成工業株式会社 肌荒れ予防又は改善剤
JP5669436B2 (ja) * 2010-05-18 2015-02-12 ポーラ化成工業株式会社 組成物
JP5669437B2 (ja) * 2010-05-18 2015-02-12 ポーラ化成工業株式会社 組成物
JP5911209B2 (ja) * 2011-06-14 2016-04-27 ポーラ化成工業株式会社 皮膚外用剤
JP2013018713A (ja) * 2011-07-07 2013-01-31 Pola Chemical Industries Inc 皮膚外用剤
JP6086706B2 (ja) * 2012-11-14 2017-03-01 ポーラ化成工業株式会社 高い紫外線吸収効果を有する皮膚外用組成物
WO2015152384A1 (ja) 2014-04-03 2015-10-08 ポーラ化成工業株式会社 Ｄ－パントテニルアルコールからなるメラニン産生抑制剤、及び該メラニン産生抑制剤を含む美白化粧料
FR3029412B1 (fr) * 2014-12-04 2018-01-26 Societe D'exploitation De Produits Pour Les Industries Chimiques Seppic Utilisation de derives n-acyles d'acide amines esterifies avec le 1,3-butanediol, comme agent antivieillissement de la peau humaine
FR3029410B1 (fr) * 2014-12-04 2016-12-30 Soc D'exploitation De Produits Pour Les Ind Chimiques Seppic Utilisation d'esters de 1,3-butanediol et de derives n-acyles d'acides amines comme agent de brunissage et/ou de bronzage de la peau humaine
EP4008304A3 (en) * 2016-06-24 2022-07-20 Pola Chemical Industries Inc. External preparation for skin for wrinkle improvement
KR102042967B1 (ko) * 2017-03-07 2019-11-11 코스맥스 주식회사 푸코실락토오스를 포함하는 피부 노화 개선용 화장료 조성물
MX2021015351A (es) * 2019-06-24 2022-04-07 Rossana Castellana Formulaciones para uso odontologico y dermatologico que contienen sales de tricloroacetato e hidroxiacidos.

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1035855B (de) 1957-06-29 1958-08-07 Hans Schwarzkopf Chem Fab Haut- und Haarpflegemittel
JPS53149926A (en) * 1977-05-18 1978-12-27 Kowa Co Methylmethionine sulfonium derivative
JPS6119511A (ja) 1984-07-06 1986-01-28 Mitsubishi Electric Corp 放電加工方法とその装置
LU85558A1 (fr) 1984-09-28 1986-04-03 Oreal Nouveaux derives naphtaleniques a action retinoique,leurs procedes de preparation et compositions medicamenteuse et cosmetique les contenant
US4757066A (en) 1984-10-15 1988-07-12 Sankyo Company Limited Composition containing a penem or carbapenem antibiotic and the use of the same
JPS61289016A (ja) 1985-06-17 1986-12-19 Pola Chem Ind Inc 皮膚外用剤
JPH0657652B2 (ja) 1985-07-19 1994-08-03 鐘紡株式会社 皮膚老化防止化粧料
IL80270A0 (en) 1985-10-11 1987-01-30 Cird Naphthalene derivatives,their preparation and pharmaceutical compositions containing them
JPH075461B2 (ja) * 1986-04-10 1995-01-25 三共株式会社 副作用の軽減されたペネム型またはカルバペネム型抗生物質製剤
DE3727897A1 (de) * 1987-08-21 1989-03-02 Degussa Verfahren zur herstellung von n-acylierten mercapto-(alpha)-aminosaeuren
JP2985181B2 (ja) 1989-05-31 1999-11-29 日本電気株式会社 多重変換装置
JP2999301B2 (ja) 1991-07-25 2000-01-17 協和醗酵工業株式会社 化粧料
US5296500A (en) 1991-08-30 1994-03-22 The Procter & Gamble Company Use of N-acetyl-cysteine and derivatives for regulating skin wrinkles and/or skin atrophy
TW222591B (ru) 1991-08-30 1994-04-21 Procter & Gamble
EP0632038B1 (en) 1992-01-27 2001-08-22 Chugai Seiyaku Kabushiki Kaisha Methotrexate derivative
FR2738484B1 (fr) 1995-09-07 1997-10-03 Oreal Utilisation de l'acide cysteique ou homocysteique pour favoriser la desquamation de la peau ou stimuler le renouvellement epidermique
ATE236632T1 (de) * 1995-11-06 2003-04-15 Univ Pittsburgh Inhibitoren der protein-isoprenyl-transferase
JP3569448B2 (ja) 1997-07-14 2004-09-22 鹿島石油株式会社 Ｎ−アシルアミノ酸及びこれを用いた化粧料
JPH1149629A (ja) 1997-07-31 1999-02-23 Shiseido Co Ltd 美白用化粧料
JPH1149628A (ja) 1997-07-31 1999-02-23 Shiseido Co Ltd しわ改善用化粧料
EP1063982B1 (en) 1998-03-27 2007-02-14 Genentech, Inc. Antagonists for treatment of cd11/cd18 adhesion receptor mediated disorders
GB9828442D0 (en) 1998-12-24 1999-02-17 Karobio Ab Novel thyroid receptor ligands and method II
US20030229141A1 (en) * 1999-01-08 2003-12-11 Yu Ruey J. N-acetyl cysteine and its topical use
JP2001192317A (ja) 2000-01-06 2001-07-17 Shiseido Co Ltd マトリックスメタロプロテアーゼ阻害剤
US6534038B2 (en) 2000-04-07 2003-03-18 Bristol-Myers Squibb Pharma Company Ternary ligand complexes useful as radiopharmaceuticals
US20020010128A1 (en) 2000-04-13 2002-01-24 Parks Thomas P. Treatment of hyperproliferative, inflammatory and related mucocutaneous disorders using inhibitors of mevalonate synthesis and metabolism
US7118736B2 (en) 2001-02-22 2006-10-10 L'oreal Hair relaxer compositions comprising at least one hydroxide compound and at least one activating agent, and methods of using the same
ITMI20011022A1 (it) 2001-05-17 2002-11-17 Indena Spa Composizioni farmaceutiche e cosmetiche contro l'invecchiamento cutaneo
JP2003137807A (ja) 2001-11-01 2003-05-14 Miyagi Kagaku Kogyo Kk コラーゲン産生促進剤、それを含む化粧品、食品および医薬品ならびに皮膚疾患の予防または改善用外用剤
JP2003267856A (ja) 2002-03-18 2003-09-25 Showa Denko Kk しわ防止用化粧料
EP1534693A2 (en) * 2002-09-06 2005-06-01 Elan Pharmaceuticals, Inc. 1, 3-diamino-2-hydroxypropane prodrug derivatives
WO2004024939A2 (en) 2002-09-13 2004-03-25 Georgetown University Ligands for the peroxisome proliferator-activated receptor, and methods of use thereof
JP2005089304A (ja) 2003-09-12 2005-04-07 Nippon Menaade Keshohin Kk 炎症性サイトカインの産生抑制剤
JP4341501B2 (ja) 2004-08-10 2009-10-07 東亞合成株式会社 チロシナーゼ活性阻害剤
US20060166901A1 (en) 2005-01-03 2006-07-27 Yu Ruey J Compositions comprising O-acetylsalicyl derivatives of aminocarbohydrates and amino acids
CN101128117A (zh) * 2005-01-03 2008-02-20 吕伊·J·于 包含氨基糖类和氨基酸的o-乙酰水杨基衍生物的组合物
JP2007191396A (ja) 2005-01-07 2007-08-02 Rohto Pharmaceut Co Ltd 皮膚外用剤
JP4838537B2 (ja) 2005-05-25 2011-12-14 株式会社 資生堂 不全角化抑制剤、毛穴縮小剤又は肌荒れ防止・改善剤及び皮膚外用組成物
US8088804B2 (en) * 2005-12-15 2012-01-03 Pfizer Inc. N-hydroxyamide derivatives possessing antibacterial activity
JP2008105976A (ja) 2006-10-24 2008-05-08 Shinichiro Isobe 化粧用組成物

Also Published As

Publication number Publication date
EP3173063B1 (en) 2019-12-25
RU2011124914A (ru) 2012-12-27
EP2356979A4 (en) 2012-09-05
CA2742909A1 (en) 2010-05-27
TWI474837B (zh) 2015-03-01
RU2503443C2 (ru) 2014-01-10
EP3173063A1 (en) 2017-05-31
JP2015147768A (ja) 2015-08-20
IL212909A0 (en) 2011-07-31
US20110245343A1 (en) 2011-10-06
JP6239543B2 (ja) 2017-11-29
WO2010058730A1 (ja) 2010-05-27
CA2742909C (en) 2017-12-19
JP6225228B2 (ja) 2017-11-01
AU2009318483B2 (en) 2015-03-19
ES2650252T3 (es) 2018-01-17
KR101657323B1 (ko) 2016-09-13
BRPI0921303B8 (pt) 2022-05-10
CN102215812B (zh) 2014-09-10
MX2011004006A (es) 2011-05-19
IL212909A (en) 2015-02-26
AU2009318483A1 (en) 2010-05-27
JP5746864B2 (ja) 2015-07-08
JPWO2010058730A1 (ja) 2012-04-19
HK1160405A1 (en) 2012-08-17
JP2017008101A (ja) 2017-01-12
US8835498B2 (en) 2014-09-16
EP2356979B1 (en) 2017-10-25
EP2356979A1 (en) 2011-08-17
MY159355A (en) 2016-12-30
BRPI0921303B1 (pt) 2022-04-12
BRPI0921303A2 (pt) 2015-12-29
KR20110086743A (ko) 2011-07-29
CN102215812A (zh) 2011-10-12
ES2781401T3 (es) 2020-09-01
TW201023902A (en) 2010-07-01

Similar Documents

Publication Publication Date Title
UA107919C2 (en) Anti-wrinkle means
CL2012001911A1 (es) Compuestos derivados de fumarato; composicion farmaceutica que los comprende; y su uso en el tratamiento de una enfermedad inflamatoria o neurodegenerativa.
EA201390908A1 (ru) Производные бицикло[3.2.1]октиламида и их применение
TN2011000172A1 (en) Therapeutic antiviral peptides
CL2009000349A1 (es) Compuestos derivados de 4,5-dihidro-oxazol-2-ilamina; procedimiento de preparacion; composicion farmaceutica; y su uso para el tratamiento de la enfermedad de alzheimer.
CR20130023A (es) Pirazolo[1,5-a]pirimidinas para tratamiento antiviral
TN2011000279A1 (en) Novel pyrazole -4-n-alkoxycarboxamides as microbiocides
UY30498A1 (es) Nueva clase de compuestos de benzimidazolilo, sus sales, composiciones farmacéuticas conteniéndolos y aplicaciones
UY30835A1 (es) 8-alquinilxantinas y derivados
MX2009003958A (es) Nuevos derivados de 1,4-benzotiepina-1,1-dioxido sustituidos con radicales bencilo, metodo para su preparacion, productos farmaceuticos que comprenden estos compuestos y su uso.
CO6480932A2 (es) Antagonistas de la trayectoria hedgehog de ftalazina disustituida.
CY1113244T1 (el) Ενωση ουρακιλης η οποια εχει ανασταλτικη δραστικοτητα σε ανθρωπινη τριφωσφαταση δεοξυουριδινης ή αλας αυτης
PH12015501993A1 (en) Pyrazole-amide compound and medicinal uses therefor
MY161132A (en) Novel herbicides
IN2012DN03182A (ru)
MX2011007998A (es) Nuevos herbicidas.
UA102289C2 (ru) Гербициды, полученные из циклопентадиона
ECSP099722A (es) Compuestos de pirido [2, 3-d] pirimidina-7-ona como inhibidores de pi3k-alfa para el tratamiento del cáncer
MX2011007932A (es) Herbicidas nuevos.
UA106880C2 (uk) Нові гербіциди
CO6321280A2 (es) Nueva clase espiro piperidinas para el tratamiento de enfermedades neurodegenerativas
UA111324C2 (uk) Агент для профілактики або зменшення пігментації
TN2011000355A1 (en) Novel microbiocides
MA32834B1 (fr) 3-aminocyclopentanecarboxamides servant de modulateurs de recepteurs de chimiokines
PH12015501146A1 (en) Hydantoin derivative